 The Nation of Georgias Prime Minister and Minister of Health have issued an Emergency Use Authorization for NRx Pharmaceuticals Incs NASDAQ: NRXP intravenous Zyesami aviptadil to treat critical COVID-19 patients. The company says that the first doses will arrive in the Nation of Georgia within 24 hours. 